259 related articles for article (PubMed ID: 27838134)
1. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study.
Sato A; Aonuma K; Watanabe M; Hirayama A; Tamaki N; Tsutsui H; Toyoaki M; Ogawa H; Akasaka T; Yoshimura M; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K; Saito Y;
Int J Cardiol; 2017 Jan; 227():424-429. PubMed ID: 27838134
[TBL] [Abstract][Full Text] [Related]
2. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
[TBL] [Abstract][Full Text] [Related]
3. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
4. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
[TBL] [Abstract][Full Text] [Related]
5. [Contrast-induced nephropathy after cardiac catheterization: a prospective study of 180 patients].
Mghaieth F; Ayari J; Ben Rejeb R; Mbarki S; Farhati A; Larbi N; Boussaada R; Mourali MS; Mechmeche R
Tunis Med; 2012 Apr; 90(4):320-7. PubMed ID: 22535348
[TBL] [Abstract][Full Text] [Related]
6. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
7. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for hemodialysis and mortality in patients with contrast-induced nephropathy.
Lai HM; Aronow WS; Chugh SS; Pudasaini B; Goel A; Garrick R
Am J Ther; 2013; 20(6):607-12. PubMed ID: 22820714
[TBL] [Abstract][Full Text] [Related]
10. Clinically significant contrast induced acute kidney injury after non-emergent cardiac catheterization--risk factors and impact on length of hospital stay.
Kashif W; Khawaja A; Yaqub S; Hussain SA
J Coll Physicians Surg Pak; 2013 Dec; 23(12):842-7. PubMed ID: 24304985
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
[TBL] [Abstract][Full Text] [Related]
12. [Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis].
Bouzas-Mosquera A; Vázquez-Rodríguez JM; Calviño-Santos R; Peteiro-Vázquez J; Flores-Ríos X; Marzoa-Rivas R; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Vázquez-González N; Castro-Beiras A
Rev Esp Cardiol; 2007 Oct; 60(10):1026-34. PubMed ID: 17953923
[TBL] [Abstract][Full Text] [Related]
13. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
[TBL] [Abstract][Full Text] [Related]
14. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
[TBL] [Abstract][Full Text] [Related]
15. Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention.
Sato A; Hoshi T; Kakefuda Y; Harunari T; Watabe H; Hiraya D; Akiyama D; Abe D; Takeyasu N; Aonuma K
J Cardiol; 2015 Nov; 66(5):417-22. PubMed ID: 25623482
[TBL] [Abstract][Full Text] [Related]
16. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
Garcia S; Ko B; Adabag S
Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
[TBL] [Abstract][Full Text] [Related]
17. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
[TBL] [Abstract][Full Text] [Related]
18. Contrast-induced kidney injury: how does it affect long-term cardiac mortality?
Andreis A; Budano C; Levis M; Garrone P; Usmiani T; D'Ascenzo F; De Filippo O; D'Amico M; Bergamasco L; Biancone L; Marra S; Colombo A; Gaita F
J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):908-915. PubMed ID: 28678146
[TBL] [Abstract][Full Text] [Related]
19. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
20. Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study.
Chen F; Liu F; Lu J; Yang X; Xiao B; Jin Y; Zhang J
Eur J Med Res; 2018 May; 23(1):23. PubMed ID: 29776437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
